首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   18295篇
  免费   1761篇
  国内免费   40篇
耳鼻咽喉   144篇
儿科学   513篇
妇产科学   327篇
基础医学   2684篇
口腔科学   400篇
临床医学   2175篇
内科学   3852篇
皮肤病学   449篇
神经病学   1431篇
特种医学   599篇
外科学   3053篇
综合类   476篇
一般理论   10篇
预防医学   1543篇
眼科学   249篇
药学   1257篇
  1篇
中国医学   9篇
肿瘤学   924篇
  2021年   200篇
  2020年   168篇
  2019年   260篇
  2018年   254篇
  2017年   240篇
  2016年   260篇
  2015年   279篇
  2014年   393篇
  2013年   549篇
  2012年   874篇
  2011年   816篇
  2010年   449篇
  2009年   469篇
  2008年   748篇
  2007年   811篇
  2006年   822篇
  2005年   803篇
  2004年   751篇
  2003年   725篇
  2002年   663篇
  2001年   566篇
  2000年   661篇
  1999年   522篇
  1998年   237篇
  1997年   236篇
  1996年   225篇
  1995年   195篇
  1994年   190篇
  1993年   196篇
  1992年   498篇
  1991年   468篇
  1990年   411篇
  1989年   407篇
  1988年   403篇
  1987年   371篇
  1986年   360篇
  1985年   331篇
  1984年   326篇
  1983年   233篇
  1982年   155篇
  1981年   151篇
  1980年   137篇
  1979年   264篇
  1978年   164篇
  1977年   131篇
  1976年   151篇
  1975年   125篇
  1974年   166篇
  1973年   163篇
  1972年   157篇
排序方式: 共有10000条查询结果,搜索用时 109 毫秒
1.
Developmental dysplasia of the hip is a hip abnormality that ranges from mild acetabular dysplasia to irreducible femoral head dislocations. While 2-D B-mode ultrasound (US)-based dysplasia metrics or disease metrics are currently used clinically to diagnose developmental dysplasia of the hip, such estimates suffer from high inter-exam variability. In this work, we propose and evaluate 3-D US-derived dysplasia metrics that are automatically computed and demonstrate that these automatically derived dysplasia metrics are considerably more reproducible. The key features of our automatic method are (i) a random forest-based learning technique to remove regions across the coronal axis that do not contain bone structures necessary for dysplasia-metric extraction, thereby reducing outliers; (ii) a bone segmentation method that uses rotation-invariant and intensity-invariant filters, thus remaining robust to signal dropout and varying bone morphology; (iii) a novel slice-based learning and 3-D reconstruction strategy to estimate a probability map of the hypoechoic femoral head in the US volume; and (iv) formulae for calculating the 3-D US-derived dysplasia metrics. We validate our proposed method on real clinical data acquired from 40 infant hip examinations. Results show a considerable (around 70%) reduction in variability in two key 3-D US-derived dysplasia metrics compared with their 2-D counterparts.  相似文献   
2.
3.
Graefe's Archive for Clinical and Experimental Ophthalmology - Retinal microvascular endothelial dysfunction is thought to be of importance in the development of ocular vascular diseases....  相似文献   
4.
5.
6.
Objective: Blenderized diets are gaining increasing popularity among enteral tube users. Connectors in gastrostomy tubes (G-tubes) are undergoing standardization to reduce misconnections. These standardized G-tubes are referred to as ENFit G-tubes. This study was performed to quantify the in vitro performance of existing (legacy) G-tubes and compare them with ENFit G-tubes for blenderized diets.

Method: Patient blenderized diet recipes and practices were obtained through patient advocacy groups. Different blenders and blending times were studied. Five legacy G-tube brands and three corresponding ENFit brands, sized between 14?Fr and 24?Fr, were studied under gravity and push modes of feeding.

Results: Considering both thin and thick blenderized gravity mode diets, an average increase in feeding time from 20?minutes to 32?±?18?minutes in transitioning from legacy to ENFit was observed with standard G-tubes, compared to 22?±?3.5?minutes for low profiles. For push-mode diets, a 60-second push with standard ENFit G-tubes was easier compared to standard legacy G-tubes (61%?±?21% as much force), but faster 5-second pushes required considerably more effort for ENFit standard G-tubes (167%?±?96%). Low-profile ENFit G-tubes required slightly less effort compared to low-profile legacies for both 60-second and 5-second pushes (72%?±?22% and 90%?±?19%, respectively). Clogging was common in both legacy and ENFit devices, particularly under gravity mode.

Conclusions: For a push mode of feeding, patients will largely be unimpacted after the transition to ENFit. For a gravity mode of feeding, some ENFit users may need higher-powered blenders and should expect increased feeding times.  相似文献   

7.
8.
9.

Introduction

Induction chemotherapy with cytarabine and an anthracycline (7+3) remains the standard of care for acute myeloid leukemia (AML).

Patients and Methods

We retrospectively analyzed 183 newly diagnosed AML patients to compare the utility of rapid peripheral blast clearance (PBC), day of peripheral blast disappearance, residual blasts, and cellularity at day 14 bone marrow biopsy (D14BM) in predicting clinical response to 7+3 induction, overall survival (OS), and relapse-free survival (RFS).

Results

In multivariable logistic regression analysis, day 2 PBC > 85% [P = .0016] was the only predictor of remission status, with sensitivity and specificity of 75%. Peripheral blast disappearance within 5 days after induction and < 10% cellularity in D14BM predicted superior OS and RFS in multivariate analysis. Median follow-up of patients was 28 months since diagnosis. Two-year OS and RFS for patients with ≤ 10% versus > 10% cellularity at D14BM was 60.6% [95% confidence interval (CI), 50.8%-72.2%] versus 32.5% [95% CI, 23.0%-45.8%], and 51.9% [95% CI, 41.9%-64.3%] versus 28.8% [95% CI, 19.1%-43.4%], respectively [P = .0003 for OS and .002 for RFS].

Conclusion

Rapid PBC after 7+3 induction showed a significant improvement in specificity compared with D14BM, with similar sensitivity. Neither of these methods were reliably specific tools for the decision of early reinduction, despite their prognostic value. Our findings indicate that morphological cellularity in D14BM is an independent prognostic factor for OS and RFS, regardless of blast percentage, and that ≤ 10% cellularity defines D14BM hypoplasia.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号